Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of a Thin Strut Metallic Stent: the Elixir DynamX Novolimus Eluting Coronary Stent System

Trial Profile

Evaluation of a Thin Strut Metallic Stent: the Elixir DynamX Novolimus Eluting Coronary Stent System

Active, no longer recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 15 Feb 2019

At a glance

  • Drugs Novolimus (Primary)
  • Indications Myocardial ischaemia
  • Focus Therapeutic Use
  • Sponsors Elixir Medical Corporation
  • Most Recent Events

    • 15 Feb 2019 Last check against ClinicalTrials.gov: US National Institutes of Health
    • 06 Feb 2019 Planned End Date changed from 1 Apr 2021 to 31 Dec 2021.
    • 06 Feb 2019 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top